-0.10 | -0.51%
| Price and Volume | |
|---|---|
| Recent Price | 19.32 |
| 52 Week High | 31.17 |
| 52 Week Low | 17.62 |
| Avg. Daily Vol. (Mil) | 0.49 |
| Beta (3 year) | 0.55 |
| Share Related Items | |
| Mkt Cap (Mil) | 1,107.73 |
| Shares Out (Mil) | 57.34 |
| Float (Mil) | 52.87 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.20 |
| Current Ratio | 3.00 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 18.90 |
| Price/Sales | 2.49 |
| Price/Book | 4.03 |
| Price/Cash Flow | 16.20 |
| Per Share Data | |
| Earnings | 1.02 |
| Sales | 7.76 |
| Book Value | 4.80 |
| Cash Flow | 1.20 |
| Business Summary | |
|---|---|
| Masimo Corporation is a global medical technology company that develops, manufactures and markets noninvasive patient monitoring products that improve patient care. | |
| General Information | |
| 40 Parker
Irvine, CA 92618 |
|
| www.masimo.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 2548 | |
| CEO: Mr. Joe E. Kiani | |
| Short Interest | |
| Current Month (Mil) | 4.08 |
| Previous Month (Mil) | 4.02 |
| Short Interest Ratio (Days) | 8.90 |
| Management Effectiveness | |
| Return on Equity | 22.40 |
| Return on Assets | 16.20 |
| Return on Investments | 22.40 |
| Profitability | |
| Gross Margin | 68.20 |
| EBIT Margin | 18.60 |
| Profit Margin | 13.80 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
106.76
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet